Join
Live feed
·
PRReleasevia Quantisnow
LENSAR Inc. logo

LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY

ByQuantisnow·Wall Street's wire, on your screen.
LNSR· LENSAR Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LNSR (LENSAR Inc.) and more on Quantisnow.